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1  | T WO -SIGNAL MODEL OF B CELL 
AC TIVATION
Bretcher and Cohn's two-signal hypothesis of lymphocyte activation 
predicts that antigen (Ag) receptor signaling alone is insufficient for 
full activation of lymphocytes and their differentiation into effector 
cells.1,2 While highly crosslinking-Ags, for example, bacterial capsular 
polysaccharides and repetitive motifs in viral capsids, induce pro-
longed and persistent B cell receptor (BCR) signaling in B cells that 
can bypass the requirement of secondary signals,3-5 in most physi-
ological settings the “second signal” is necessary for B cell prolifer-
ation and differentiation into antibody (Ab)-secreting plasma cells 
(PCs). These signals may be provided by various molecular factors 
and cellular sources.6 B cell responses that require secondary, con-
tact-dependent (cognate) signals from helper T cells (Th) are called 
T-dependent. T-independent responses encompass all other scenar-
ios that trigger B cell proliferation and differentiation into PCs.
1.1 | T-independent responses
In the absence of T cell help, toll-like receptor ligands from microbial 
components (PAMPs), for example, lipopolysaccharides (LPS), or cell 
damage-associated ligands (DAMPs) may synergize with BCR sign-
aling to promote B cell responses. Other accessory signals include 
BAFF and April TNF-family members, CD40 ligand, and cytokines, 
IL21, IL4, IL6, IL10, and IL21. These signals may be initiated under 
specific conditions by various types of innate or innate-like cells, such 
as iNKT cells, neutrophils, monocyte-derived cells and/or dendritic 
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Abstract
Diverse B cell responses are important for generating antibody-mediated protection 
against highly variable pathogens. While some antigens can trigger T-independent 
B cell proliferation and short-term antibody production, development of long-term 
humoral immunity requires T-dependent B cell responses. The “two-signal” model 
of B cell activation has long been invoked to explain alternate B cell recruitment 
into immune response to foreign antigens vs. induction of tolerance to self-antigens. 
However, a number of other factors appear to influence the fate of mature B cells 
responding to antigen in vivo. In this review, we will discuss how various spatiotem-
poral scenarios of antigen access into secondary lymphoid organs, antigen valency 
and cellular environment of antigen acquisition by B cells, duration of B cell access to 
antigen and the timing of T cell help may affect follicular B cell fate, including death, 
survival, anergy, and recruitment into T-dependent responses. We will also highlight 
unresolved questions related to B cell activation and tolerance in vivo that may have 
important implications for vaccine development and autoimmunity.
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cells (DCs), and possibly mast cells. T-independent responses are 
predominantly mounted by B1 and MZ B cells and lead to low affin-
ity, short-term IgM antibody-mediated humoral immunity (reviewed 
in Ref. 6). However, in some cases they can generate long-lived Ab 
and memory responses or synergize with T cell-derived signals to 
modulate or potentiate B cell responses.7-12
1.2 | T-dependent responses
Efficient generation of long-lived memory and plasma cells (PC) and 
generation of high-affinity Abs to Ags that contain proteins or pep-
tides require T cells and thus are referred to as T-dependent anti-
body responses. Activated B cells internalize Ag-bound BCRs and 
direct them to endosomes, where antigenic proteins are processed 
into peptides and loaded onto major histocompatibility complex II 
(MHCII) molecules. T-helper (Th) cells that recognize pMHCII/pep-
tide complexes presented on Ag-primed B cells through their T cell 
receptor (TCR) can engage in cognate interactions and provide par-
ticularly potent B cell-stimulating factors, including the following: 
SLAM family members, CD40 ligand and cytokines such as IL21 and 
IL4 that promote B cell survival, proliferation and differentiation (re-
viewed in Ref. 13). As in T-independent responses, in T-dependent 
responses B cells generate short-lived PCs and memory cells that 
express immunoglobulins of low affinity toward Ag. However, 
T-dependent Ags also lead to robust and prolonged formation of 
microanatomical structures in the B cell follicles of secondary lym-
phoid organs (SLOs) called germinal centers (GCs).13,14 Within GCs, 
B cells undergo a process called affinity maturation where cells 
expressing the highest affinity BCRs are selected. GCs give rise to 
high affinity, class-switched memory B cells, and long-lived PCs that 
migrate to the bone marrow, the gut or mammary glands, and can 
persist for months/years secreting high-affinity antibodies.15 Long-
lasting term, high affinity, class-switched Abs are a hallmark of the 
T-dependent humoral response. Thus, understanding the factors 
that control B cell recruitment into T-dependent responses is critical 
for design and implementation of measures that promote durable 
humoral immunity to pathogens, including improved vaccines.
Recruitment of epitope-specific B cells into immune response de-
pends on the initial frequency of these B cells in the circulation.16-18 
At the same time, participation of individual B cell clones in the 
T-dependent responses is limited by the avidity of their interaction 
with Ag19,20 and B cell apoptosis.21 While B cell Ag acquisition and pre-
sentation to Th cells, as well as cognate T-helper signals are known to 
be essential,13,22 other features that affect survival and recruitment of 
activated B cells into T-dependent response are less well understood.
In this review, we will consider the additional factors that can 
vary in an immune responses to infection or immunization, and may 
affect individual B cell's recruitment into T-dependent responses vs 
development of tolerance and/or antigen-induced cell death (AICD). 
We will focus on the early events in the recruitment of follicular B 
cells into T-dependent responses since these are the dominant B cell 
population in SLOs and the main responders to T-dependent Ags.
2  | SPATIOTEMPOR AL SCENARIOS OF 
FOLLICUL AR B CELL AC TIVATION
The first step in B cell activation is the BCR-mediated binding to Ag 
that leads to BCR signaling, Ag internalization, processing, and load-
ing of antigenic peptides on MHCII that, along with upregulated ac-
cessory molecules, for example, CD86, provide signals to Th cells. 
This must be followed by acquisition of cognate help from Th cells. 
The spatiotemporal dynamics of these events depends greatly on 
the anatomy of SLOs, the types of Ags that reach SLOs by passive 
drainage or active delivery,23-26 and multiple molecular cues that 
orchestrate movements of lymphocytes within SLOs at different 
stages of their activation.27 In this section, we will provide an over-
view of various spatiotemporal scenarios of follicular B cell activa-
tion in SLO. In the following sections, we will discuss how variable 
timing and cellular context of B cell exposure to Ag and T cell help 
in SLO may affect B cell recruitment into T-dependent responses.
2.1 | Anatomy of spleen, lymph nodes, and 
peyer's patches
The lymph nodes (LNs) and the white pulp of the spleen are com-
prised of a central T zone bordered by B cell follicles with interfollicu-
lar regions (in LNs) or bridging channels (in spleen) between adjacent 
follicles that are more enriched with T cells, macrophages (MΦ), and 
dendritic cells (DCs) (Figure 1A,B). Within the spleen, follicles are 
bordered by the marginal zone (MZ) that is quickly exposed to Ags 
following their entry into the bloodstream, while within the LNs fol-
licles are adjacent to the subcapsular sinus (SCS), where lymph-born 
Ags from the upstream lymphatics are delivered (Figure 1). Both the 
sinuses and interfollicular areas/bridging channels contain special-
ized cells that facilitate Ag capture and presentation.27,28 The struc-
ture of peyer's patches (PP) is somewhat distinct. While small T cell 
zones are present there as well, PP are dominated by B cell follicles, 
follicle-associated epithelium (FAE), and sub-epithelial dome (SED) 
that is positioned between FAE and follicles. Luminal Ags are trans-
ported through FAE-associated M cells and are quickly spread within 
DC-rich SEDs.29 While spatial/temporal access of luminal Ags into 
B cell follicles in PP is not yet well characterized, it has been exten-
sively described for rodent LNs and spleen.
2.2 | How B cells encounter antigen
Ags distribution and its acquisition by specific B cells have been 
shown to depend on a number of factors, including Ag size, route 
of entry, and availability of preexisting Ag-specific Abs and their 
isotypes.23-26 Ags of various sizes have differential access to the 
SLO parenchyma.30,31 Smaller Ags (<70 kDa) can enter B cell fol-
licles from the SC or MZ sinuses through follicular conduits and to 
some extent via direct diffusion across the floor of the sinus32-35 
and can rapidly access Ag-specific B cells in the follicles (Figure 1C). 
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In contrast, large Ags (eg, viruses, bacteria, and large proteins and 
protein complexes) initially localize to a few restricted locations 
(Figure 1D). In the LNs, these locations include interfollicular and 
medullary regions, SC, and cortical, as well as medullary lymphatic 
sinuses.35-39 B cells migrate to these regions in a random fashion 
and can acquire their cognate Ags at these sites, in some cases 
in association with local macrophages or DCs. Intravital imaging 
studies visualizing B cell acquisition of Ags from SCS macrophages 
found that these encounters were relatively brief (ranging from 
5 minutes to a few tens of minutes).36,37 Additionally, B cells may 
acquire large Ags from DCs that migrate to the LNs and bring 
internalized Ags from upstream lymphatics to the interfollicular 
areas and T-B border.40 A non-degradative pathway of Ag recy-
cling observed in DCs promotes retention of some intact Ag for B 
cell acquisition.41
Pre-existing Abs or direct Ag binding of complement compo-
nent C3b can lead to rapid redistribution of Ags from the restricted 
regions described above to the center of the follicles. The immune 
F I G U R E  1   Spatiotemporal scenarios of B cell encounters with cognate Ags in draining LNs during the primary immune responses. 
A, B, Schematics of lymph node (A) and lymph node fragment (B) anatomy. C, D, Scenarios of the small soluble (<70 kDa, in C) and large 
(>70 kDa, in D) Ag access into the draining LNs, Ag-dependent activation of cognate B cells and their relocalization in the follicles. C, Small 
Ags permeate B cell follicles promoting rapid exposure of Ag-specific B cells to the Ag. D, The access of large Ags into LN parenchyma is 
restricted. B cells may acquire large Ags from the subcapsular sinus (SCS) and SCS macrophages, ΜΦ (1), interfollicular or medullary regions 
(2), from dendritic cells (DCs) that bring the Ag from the site of infection (3), or cortical LYVE1 + lymphatic sinuses (4). In primary immune 
response after Ag-dependent activation cognate B cells upregulate Ebi2 and move to the back of the follicles. They then upregulate CCR7 
and move to the B-T zone interface, where they may encounter cognate Th cells. The initial duration of B cell exposure to large Ags in SLO 
is likely to be transient, in contrast to the more continuous exposure to small soluble Ags. In the presence of immune complexes, Ags are 
rapidly (12-24 h) transported and deposited onto follicular dendritic cells (FDCs). In that case, B cells may be more likely to encounter Ag in a 
recurrent fashion on FDCs (not shown). Red circle: interaction between cognate B and Th cells
(A) (B)
(C) (D)
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complexes are transported by naive B cells in the LNs or MZ B cells 
in the spleen and deposited on follicular dendritic cells (FDCs), large 
stromal cells located near the middle of the follicle that have exten-
sive dendritic processes, and high expression of the complement 
receptors CD21 (CR2) and CD35 (CR1).37,42-45 Ags can remain at-
tached to FDCs for extended periods of time; they can cycle through 
non-degrading compartments and resurface periodically, where they 
are available for acquisition by Ag-specific B cells and GC B cells.46,47
In addition to the effects of size, biophysical properties, and 
presence of Abs, spatiotemporal dynamics of foreign Ag acquisi-
tion by B cells may vary depending on the dose of Ag, duration of 
its delivery to SLO, the rate of Ag proteolysis into smaller antigenic 
fragments, and clearance. It also depends on the patterns of B cell 
migration and localization in SLO.
2.3 | B cell migration after Ag-dependent activation
The coordinated migration of B cells following Ag stimulation de-
pends on the expression of several different G protein-coupled re-
ceptors (GPCRs) on B cells and spatial distribution of their ligands 
including chemokines and other factors produced by stroma and 
other cell types in the SLO.27,28 Follicular stromal cells express 
CXCL13, which promotes B cell localization and migration within B 
cell follicle via CXCR5 receptor.48 Critical to the positioning of B cells 
following their initial activation is the increased expression of the 
Epstein-Barr virus-induced protein 2 receptor (EBI2 or GPR183).49-51 
EBI2 ligand, 7ɑ,25-dihydroxycholesterol (7ɑ,25-OHC), is located in 
higher concentrations at the follicular perimeter than in the center. 
7ɑ,25-OHC and EBI2 receptor promote the initial movement of ac-
tivated B cells toward the back of the follicle where B cells may ac-
quire additional Ags derived from the MZ or SC sinuses.50-53 Within 
6 hours following Ag stimulation, B cells upregulate the chemokine 
receptor CCR7, which leads to their relocalization to the border of 
the follicles and the CCL19 and CCL21-rich T cell zone and inter-
follicular regions (Figures 1C,D, and 2).54,55 Balanced responses of 
CXCR5, CCR7, and EBI2 receptors to their respective ligands in SLO 
promote migration and uniform distribution of activated B cells at 
the T/B border,27,56 where B cells may encounter cognate Th cell 
help and get recruited into primary T-dependent humoral immune 
response (Figures 1C,D, and 2).
2.4 | Scenarios of transient or recurrent exposure of 
B cell to Ags in vivo
Sequential relocalization of B cells following initial Ag-driven activa-
tion in combination with varied patterns of Ag distribution within SLO 
determines different temporal scenarios of the B cell's subsequent ex-
posure to foreign Ags. When Ags are restricted to SCS, interfollicular, 
F I G U R E  2   Model of B cell fate after a transient exposure to Ag. Large Ags may be initially localized to the subcapsular, medullary, 
cortical lymphatic sinuses and interfollicular areas. Naive B cells in the follicle randomly migrate to these regions where they can transiently 
acquire Ags and then leave. Ag-primed B cells relocalize to the T/B border in about 6 h. If they acquire cognate Th cell help within 24 h, 
then they proliferate and participate in the plasma cell, memory, and GC responses. If no T cell help is received within this time, then B 
cells redistribute back into the follicle and downregulate expression of Ag-derived peptide: MHCII complexes and activation markers. The 
inactivated B cells are not tolerant and do not undergo activation-induced cell death; they can reacquire Ag and T cell help and get recruited 
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and medullary regions, B cell exposure to Ags (prior to their migration 
to T-B border) is likely to be transient (Figures 1D and 2).36,37 In con-
trast, B cell exposure to small Ags, which drain into B cell follicles, is 
likely to be more continuous (Figure 1C). The continuous or recurrent 
exposure to Ag is also more likely when Ag-immune complexes are 
deposited on FDCs in the middle of the follicles.
2.5 | The anatomy and timing of T cell help
The location and timing of activated B cell's exposure to T cell help 
may be variable as well depending on the spatiotemporal patterns 
of Th cell activation in SLO, the initial frequency of the Ag-specific 
Th cells, and the presence of memory Th cells (in secondary immune 
responses).
The location of initial Ag-specific Th cells activation in SLO de-
pends on the size and biophysical properties of the draining Ags. 
Small soluble Ags (<70 kDa) can drain toward SLO and access T 
cell zone through the conduits that are sheathed by the fibroblas-
tic reticular stromal cells. These Ags may be then acquired by the 
T zone-resident DCs that initiate activation of Ag-specific Th cells 
within 24 h of Ag administration.57-59 The Ags that are larger than 
70 kDa are usually excluded from the conduits. These Ags can gain 
access to the medullary region of the draining LNs and the interfol-
licular areas35,36,39,60 where they can be captured by the local res-
ident DCs and presented to Ag-specific Th cells.61-63 Interestingly, 
some viruses (or virus-like particles, VLPs » 70 kDa) may be an excep-
tion to this rule, as they have been reported to gain some access into 
the T zone conduits and to promote local activation of Ag-specific 
Th cells.64 Moreover, TLR ligand-containing Qβ-VLPs have been 
shown to engage B cells to trigger efficient Th cell activation.65 In 
some cases, foreign Ags are presented to Th cells by the migrating 
tissue-derived DCs that arrive into the lymph-draining LNs with a 
12-24h delay after DC maturation (reviewed in Ref. 59). This scenario 
may be more important for Th cell activation following infections 
rather than immunizations with soluble Ags.59,66
The frequency of naive Ag-specific Th cells is initially very low 
(1:105-106).59,67,68 Moreover, specific MHCII restrictions, various dis-
eases, genetic disorders, age, and immunosuppressive therapies can 
further reduce the number of cognate Th cells or delay their activa-
tion.69,70 For example, HLA allotype is one of the major genetic deter-
minants of widespread variability in immune responses to a number of 
vaccines, and this is attributed to variability in efficiency of binding to 
various antigenic peptides among classes of HLA.70-72 In all cases, when 
the initial frequency of Ag-specific Th cells is low, it may take a few cy-
cles of Th cell proliferation (and a few extra days) before the Ag-primed 
B cells become engaged in cognate encounters with activated Th cells.
In contrast to the primary immune responses, in secondary re-
sponses B-Th cell cognate interactions should occur more rapidly, 
both because of the increased frequencies of memory B cells and 
memory follicular helper T cells (Tfh), as well as due to their rapid 
co-localization at the SCS where they can reacquire Ags and form 
cognate interactions.73-75
While the timing of Ag-dependent activation of B and cognate Th 
cells is likely to differ widely depending on multiple factors, distinct 
temporal scenarios of Ag and T cell help acquisition can differen-
tially affect B cell fate in vivo. This conclusion is based on the previ-
ous studies of B cell tolerance development, as well as on the more 
recent analysis of B cell survival and recruitment into T-dependent 
responses after various modes of exposure to foreign Ags and T cell 
help. This we will discuss below.
3  | TEMPOR AL DYNAMIC S OF B CELL 
E XPOSURE TO AG/T CELL HELP AND B 
CELL FATE
As discussed above, proliferation of the Ag-specific Th cells may take 
a few days. The significant consequences of limiting T cell help in the 
beginning of immune response may be a failure to recruit many of 
the Ag-primed B cells into T-dependent response. Much of the re-
search concerning the fate of Ag-activated B cells in the absence of T 
cell help comes from the studies of autoimmunity. B cells specific for 
self-Ags are unlikely to acquire T cell help, as self-reactive T cells are 
thought to be removed from the proinflammatory repertoire more 
stringently than B cells during development.76
3.1 | Insight from B cell exposure to self-
ags and tolerance
3.1.1 | Development of B cell anergy and AICD in B 
cells continuously exposed to self-Ags
Studies of autoreactive B cells have established a consensus that 
to maintain tolerance, Ag-activated B cells that do not acquire T 
cell help must be removed from the responding repertoire either 
through receptor editing, death, or induction of an unresponsive 
state termed anergy.77,78 Tolerance of the primary B cell repertoire 
to self-Ags is induced in the developing B cells, either in the bone 
marrow (BM) or in the spleen where B cells can emigrate from the 
BM at their immature stage. Immature B cells that bind self-Ag with 
high avidity undergo receptor editing or AICD, whereas induction of 
anergy is observed in B cells that undergo constant but lower ampli-
tude BCR signaling.79-81
Anergy has been first modeled in doubly transgenic (DTg) mice 
in which one transgene encodes a constitutively produced soluble 
form of the small 14 kDa protein hen egg lysozyme (HEL), and the 
second encodes a HEL-specific BCR (Ig-Tg). B cells from these mice 
exhibit downregulation of IgM BCR. When stimulated with Ag and 
T cell help in vivo, they fail to upregulate the co-stimulatory mole-
cule CD86 and generate drastically reduced or undetectable Ab re-
sponses.82-84 In addition to reduced responsiveness to Ag, anergic B 
cells have reduced lifespans compared to naive mature B cells and, 
like Ag-activated non-anergic cells, are excluded from follicles and 
localized near the T cell zones of SLOs.85,86 In addition to HEL DTg 
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mice that are characterized with very high affinity of self-Ag HEL to 
the Ig-Tg BCR, other transgenic models of B cell anergy that have 
significantly lower Ig-Tg affinity to self-Ag have been characterized 
and investigated.87-91 Therefore, while some differences have been 
reported in these mouse models, B cells that have a wide range of 
affinities to self-Ags expressed in vivo can develop tolerance and 
become anergic.
Anergy development is not restricted to immature B cells and 
can be induced in mature B cells as well. This was first shown in 
MD3-ML3 DTg mice that have very low levels of soluble HEL self-Ag 
in the uninduced state. MD3 stands for a Tg encoding HEL-specific Ig 
in B cells, while ML3 Tg encodes soluble HEL that is expressed from 
Zn-inducible promoter. Within 2 days following Zn-inducible overex-
pression of HEL, mature Ig-Tg B cells become tolerant.92 Consistent 
with that, within 2 days of adoptive transfer of mature HEL-specific 
Ig-Tg B cells into HEL-expressing Tg ML5 mice (that constitutively 
express soluble HEL), their ability to mount an Ab response to immu-
nization with HEL-HRBCs (HEL conjugated to horse red blood cells) 
is significantly reduced. These mature anergic Ig-Tg B cells downreg-
ulate IgM, but maintain high IgD expression, and undergo follicular 
exclusion and Bim-dependent disappearance within approximately 
3 days.83,92-95 The observed premature death of mature B cells oc-
curs after their continuous exposure to both soluble, as well as mem-
brane-linked self-Ags.93
On the molecular level, anergic B cells are characterized by the 
elevated basal levels of intracellular Ca2+, failed mobilization of Ca2+ 
upon crosslinking of BCRs, increased suppression of PIP3 signaling 
pathway, and increased dependence on BAFF signaling to compen-
sate for the upregulated levels of pro-apoptotic protein Bim.96-98 
On the metabolic level, anergic B cells also appear to be partially 
quiescent. They can only modestly increase glycolysis and oxygen 
consumption that are significantly upregulated in activated B cells 
and are required for Ab production.99 Finally, there is evidence for 
transcriptional reprogramming in anergic B cells.100,101
3.1.2 | Anergic B cells are abundant in 
mice and humans
Multiple studies suggested that anergic self-reactive IgDhigh IgMlow B 
cells are abundant among the endogenous B cells in mice and in hu-
mans.92,102-108 A large fraction of fully mature peripheral CD27− naive 
human B cells have reduced surface expression of IgM and are en-
riched for autoreactive cells. These cells are hypo-responsive to BCR 
crosslinking and exhibit poor proliferation, differentiation, and Ab 
production when stimulated with anti-IgM and anti-IgD Abs.106 A frac-
tion of these cells are IgD+IgM− and are called [BND].
107 A recent study 
reported elevated expression of the phosphatidylinositol 3,4,5P-3-
phosphatase PTEN in the IgD+IgMlow human B cells and demonstrated 
that PTEN was required for the maintenance of anergy in human B 
cells and for prevention of the auto-Ab response. Interestingly, PTEN 
is elevated in about 40% of CD27− human B cells and has the highest 
expression levels in IgD+IgM− [BND] subset. Consistent with important 
role of elevated PTEN in the control of anergic autoreactive B cells in 
humans, in the patients with type 1 diabetics and autoimmune thyroid 
disease PTEN expression in B cells is reduced.108 Overall, these find-
ings suggest that a large fraction of mature human B cells are present 
in the periphery in an anergic state presumably due to their chronic 
stimulation with autoantigen and that PTEN plays an important role in 
the control of B cell anergy and in prevention of autoimmunity.
3.1.3 | Rescue of B cells from tolerance by rapid T 
cell help
While prolonged exposure to self-Ags promotes development of an-
ergy and AICD in mature B cells, timely provision of T cell help can res-
cue these B cells from development of tolerance and premature death. 
T cell help can rescue Ig-Tg B cells (both mature and immature) even 
from the exposure to high-affinity membrane-bound HEL (mHEL) Ag 
and enables robust GC and Ab responses by non-anergic B cells even 
in a tolerogenic environment.93 However, T cell help must be available 
relatively soon after the Ag signal (presumably within 1-2 days) to pre-
vent induction of B cell anergy and AICD (Figure 3).93,109
3.1.4 | Reversal of B cell anergy by removal of Ag
In addition to the timing of Ag-induced signals and T cell help, an-
other factor that determines B cell fate is the duration or recurrence 
of Ag exposure and continual Ag receptor occupancy in B cells. 
Multiple studies demonstrated that B cell anergy to self-Ag was at 
least partially reversed when B cell exposure to cognate Ag was dis-
continued (Figure 3). Anergic DTg B cells transferred to non-Tg mice 
recover high surface expression of IgM and at least partially restore 
their ability to generate Abs in response to Ag and T cell help (im-
munization with HEL-sheep RBCs).110 The anergic B cells' AICD is 
discontinued after they are transferred into a naive host where they 
redistribute back from T-B border into B cell follicles.83 Analysis of 
anergic B cells from Ars/A1 transgenic mice (that specifically recog-
nize foreign Ag: hapten p-azophenlyarsonate (Ars), as well as self-
Ag: single-stranded DNA) revealed that reduced lifespan of anergic 
B cells depends on the chronic stimulation by self-Ag.90,91 Blocking 
continuous binding of Ars/A1 antigen receptor to autoantigen with 
monovalent ArsTyr leads to reduction of Ca2+ levels in Ars/A1 B cells 
to concentration of naive cells, partial restoration (50%-75%) of sur-
face IgM, and recovery in B cell potential for Ag-induced Ca2+ mobi-
lization and CD86 upregulation ex vivo.111
3.1.5 | Other scenarios of prevention or reversal of 
B cell anergy
While removal of self-Ag can lead to reversal of B cell tolerance, in 
some cases B cells continuously exposed to self-Ags can be also res-
cued from the anergic state and AICD.
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Overproduction of B cell pro-survival cytokine BAFF prevents 
development of B cell anergy and leads to autoimmunity in mice.112-
114 Consistent with a BAFF-dependent break in B cell tolerance, BAFF 
levels are often elevated in Lupus patients.115,116 While it has not 
been directly demonstrated, it is tempting to speculate that under 
some conditions local overproduction of BAFF by Ag-presenting or 
other cells in SLO may prevent B cell anergy and promote more pro-
longed survival of the continuously exposed to Ag B cells.
Exposure of anergic B cells to Ags in a form of highly multivalent 
virus-like particles117 or in complex with complement component 
C3d118 can lead to reversal of B cell anergy and generation of PCs 
and autoreactive Abs. Interestingly, exposure of the anergic HEL-
specific Ig-Tg B cells to HEL-SRBCs Ags (that are both highly multiva-
lent and may promote acquisition of sheep RBCs-specific T cell help) 
leads to efficient recruitment of the Ig-Tg B cells into GCs. Within 
GCs, they undergo rapid selection that drives their specificity away 
from self-Ags and toward foreign Ags.119-121 SRBCs can also promote 
recruitment of the endogenous IgDhighIgMlow, and thus likely anergic 
B cells into GCs in mice. Consistent with these observations, some 
human memory B cells and Abs elicited by immunizations have been 
shown to be derived from the originally autoreactive IgDhigh IgMlow 
B cell clones.119
While the observed possibility of a break in B cell anergy de-
scribed above is potentially dangerous as a trigger for autoimmu-
nity, it may be evolutionary important to ensure a broader repertoire 
of B cells to respond to pathogenic Ags and for generation of Ab 
response against the pathogens that mimic self-Ags to evade host 
immune responses (as reviewed in Ref. 122).
3.2 | Insight from B cell exposure to foreign Ags
3.2.1 | Continuous exposure to foreign Ags in the 
absence of T cell help promotes AICD in B cells
In addition to AICD due to exposure to self-Ags, foreign Ags can 
induce cognate B cell death in vivo when T cell help is delayed. 
Similarly to the observed decay of Ig-Tg B cells in the recipient mice 
that constitutively express HEL, mature Ig-Tg B cells transferred into 
wildtype recipient mice start to disappear after 24 h of recurrent iv 
administration of moderately multivalent foreign Ag, DEL-OVA (duck 
egg lysozyme conjugated to ovalbumin) (Figure 3).123 Consistent 
with this, prolonged exposure of Ig-Tg B cells to cognate Ag in vivo 
has been suggested to cause mitochondrial dysfunction in Ig-Tg B 
cells by 24 hours after administration of a large dose of Ag (100 µg 
HEL, Ig-Tg B cell threshold for activation is less than 20 ng/mL of 
HEL).92,124 In these experiments, development of mitochondrial dys-
function was inferred based on the increased MitoTracker Green 
staining. Development of mitochondrial dysfunction was also ob-
served during B cell exposure to Ag ex vivo. This effect was depend-
ent on the excessive increases in intracellular Ca2+ and correlated 
with B cell apoptosis.125
F I G U R E  3   Possible scenarios of B cell fate depending on the recurrence of BCR triggering and the timing of T cell help. Transiently 
exposed to Ag B cells, as well as B cells that see Ag in a recurrent/continuous fashion have a 24-48 h window of time to acquire help from 
cognate Th cells. In the presence of T cell help, they proliferate and may differentiate into memory, GC, and plasma cells. In the absence of T 
cell help, transiently exposed to monovalent or moderately multivalent Ags B cells return to naive -like state and can reengage into immune 
response similarly to naive B cells. In contrast to that, B cells recurrently exposed to Ag for 24-48 h in the absence of T cell help may undergo 
AICD or become anergic. Anergic B cells are also more prone to AICD. If the exposure of anergic B cells to Ag is discontinued, then within 
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3.2.2 | Transient exposure to Ags leads to B cell 
death ex vivo but not in vivo
While persistent acquisition of Ag by B cells in the absence of T 
cell help leads to B cell anergy, mitochondrial dysfunction, and 
death, the initial exposure of B cells to large foreign Ag in a pri-
mary immune response is likely to be transient rather than contin-
uous (Figure 1B). The observations made by intravital two-photon 
imaging have raised a question whether B cell fate might be dif-
ferent after the transient Ag acquisition. A study by Damdinsuren 
et al addressed this question using B cells transiently primed with 
Ag. The study found that a single round of BCR crosslinking stimu-
lated transient NFκB signaling and increased B cell sensitivity to 
CD40L, potentially priming B cells to receive T cell help, but was 
insufficient to initiate cell cycling and impaired B cell survival ex 
vivo.126 Our recent studies confirmed that B cells briefly exposed 
to foreign Ag ex vivo could be recruited into an immune response 
in the presence of T cell help in vivo (Figure 3).123,127,128 In this 
set of experiments, lysozyme-specific Ig-Tg B cells were incubated 
for 5 minutes at 37°C with HEL-OVA or DEL-OVA, extensively 
washed, and then transferred into recipient mice that were immu-
nized with OVA in adjuvant 3 days before. In the presence of cog-
nate T cell help, these Ag-pulsed B cells underwent proliferation 
and generated memory and GC B cells for a wide range of acquired 
Ag amounts, as well as plasmablasts (PB) at higher Ag doses.123 
However, while Ag-pulsed B cells underwent an expected rapid 
AICD in the absence of T cell help ex vivo,123,125,126 when trans-
ferred into unimmunized recipient mice, Ig-Tg B cells did not die. 
No Ig-Tg B cell loss (or proliferation) was observed in the SLO of 
unimmunized recipient mice within a week after the transfer of 
Ig-Tg B cells transiently pulsed ex vivo with saturating amounts of 
monovalent or moderately multivalent Ags. The observed survival 
was independent of conventional Th cells as similar persistence 
of Ag-pulsed B cells was found in the TCRα KO recipient mice 
(Figure 3).123 To summarize the above, based on our findings and 
multiple previous studies, the duration of B cell exposure to Ag in 
the absence/delay of T cell help is one of the major factors that 
determine B cells survival vs. death in vivo. Moreover, care should 
be exhibited when performing analysis of B cell survival ex vivo 
due to the enhanced apoptosis of isolated B cells in cell culture.
3.2.3 | Transiently exposed to Ag B cells return to 
“naive -like” state in vivo in the absence of rapid T 
cell help
Ag-pulsed B cells first upregulate CCR7 and migrate to T/B border in 
the SLO of unimmunized recipient mice, but in the absence of T cell help 
they downregulate CCR7 and return to B cell follicle within 24 hours 
(Figure 2). They also gradually downregulate surface expression of the 
activation marker CD86 and MHCII/Ag peptide presentation, and within 
1-2 days lose their ability to respond to T cell help by proliferation. The 
Ag-exposed Ig-Tg B cells that return to the naive -like state are capable 
of responding to protein immunization similarly to naive B cells.123,129 
Therefore, while transient exposure of B cells to Ag is sufficient to prime 
them for T cell help and for their recruitment into T-dependent immune 
response within a time window of 1-2 days, it is not sufficient to pro-
mote B cell tolerance or AICD in vivo when T cell help is further delayed. 
In contrast, such B cells return to a naive -like state and are capable 
of efficient reengaging into immune response at later time points when 
additional Ag and T cell help become accessible (Figures 2 and 3).123,129
The observations that Ag-pulsed B cells undergo rapid death in 
the absence of T cell help ex vivo, but not in vivo, suggest that ad-
ditional in vivo factors rescue the transiently exposed to Ag B cells 
from rapid AICD. This conclusion is also consistent with the ob-
served recovery of the anergic B cells' survival and responsiveness 
after Ag removal.
To summarize the above, B cell fate is determined in part by the 
duration of its exposure to Ag, and the timing of T cell help. Transient 
exposure of B cell to Ag (or self-Ag) enables it to be recruited into 
T-dependent response within 1-2 days after activation, but should 
not lead to removal of a given B cell clone from the available rep-
ertoire if T cell help is missing or delayed. In contrast, continuous B 
cell exposure to cognate foreign or self-Ags can lead to AICD that 
obviously eliminates its ability to be recruited into response, and in 
the absence of properly timed provision of T cell help anergy can 
be induced. Cessation of the antigen signal terminates anergy and 
allows cells to return to the follicle (Figures 2 and 3).
4  | ANTIGEN VALENCY AND B CELL FATE
While highly multivalent Ags are known to induce T-independent im-
mune responses, there is still insufficient understanding of how Ags 
of variable valency and epitope density affect B cell responses in 
vivo.130 In general, monovalent Ags are less likely to induce activa-
tion of B cells through BCRs that have low to intermediate affinity of 
epitope binding, while multivalent Ags engage a broader repertoire 
of Ag-specific B cells due to the higher avidity of their binding to 
BCRs. Although there is still some debate in the field, ex vivo mono-
valent Ags have been shown to promote B cell activation, but were 
less capable of efficient Ag presentation for Th cells.131-134 Whether 
poor presentation of monovalent Ags would hold in the case of B cell 
exposure to Ags in vivo in the context of dense cellular and molecu-
lar environment within SLO is unclear.
On the other end, hyper-crosslinking of BCRs has been shown 
to lead to very rapid apoptosis of mature B cells ex vivo that could 
be partially rescued by IL4 and CD40 signaling.135 More recent anal-
yses, that utilized glycopolymers or streptavidin-coated beads as 
a backbone for Ag display, confirmed correlation between Ags va-
lency/density and the rate of cognate B cell death ex vivo.125,136 In 
vivo adoptive transfer of Ig-Tg B cells into mHEL self-Ag-expressing 
mice led to somewhat faster B cell decline than in sHEL-expressing 
mice.93 Consistent with that, we found that Ig-Tg B cells transiently 
pulsed ex vivo with highly polyvalent Ags (polystyrene particles cov-
ered with duck egg lysozyme [DEL]) were significantly reduced in 
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SLO at 7 days of their transfer into recipient mice: an outcome that 
was not observed with more moderately valent Ags, even at saturat-
ing concentrations for Ig-Tg B cells.123 To summarize the above, the 
ex vivo and preliminary in vivo data suggest that in the absence of T 
cell help highly multivalent foreign Ags may induce more potent or 
rapid AICD in B cells. However, more in-depth analysis of this phe-
nomenon is required.
5  | CELLUL AR ENVIRONMENT OF AG 
ACQUISITION AND B CELL FATE
5.1 | Ag encounter by B cells occurs in the context 
of contact with other cells
Other than B cells that enter SLO after acquisition of Ag in the blood 
or lymph, B cells that encounter cognate Ags in SLO parenchyma 
should see it mostly in the context of other cells. Foreign Ags can 
be immobilized on the surface of Ag-presenting cells bound via Fc 
and complement receptors or more specific receptors for glyco-
sylated Ags, such as DC-SIGN (reviewed in Ref. 23,24). Other Ags 
that are not physically tethered to cell surface are distributed in 
between various cells in the interfollicular and medullary regions 
(eg, large particular Ags), or are found in the follicles in association 
with follicular stromal conduits and possibly outside the conduits in 
between follicular B cells (small soluble Ags). All of these sites are 
fairly densely filled with various kinds of stromal cells, lymphocytes, 
DCs, macrophages, and other cell types that are present at different 
frequencies in different locations. Therefore, even none membrane-
tethered Ags should be mostly recognized by B cells in the context 
of contact with other cells.
While some of the factors produced locally by the MΦ, DCs, and 
stromal cells may promote T-independent or amplify T-dependent 
B cell responses (as discussed in the earlier section of this review), 
others may potentially affect B cell fate during the process of Ag 
acquisition and while B cells are waiting for T cell help.
5.2 | Sialic ligands on the surface of Ag-presenting 
cells may influence B cell fate
T and B lymphocytes, as well as multiple other cell types, are cov-
ered with glycans that could modulate B cell responsiveness and fate 
after their exposure to membrane-associated self-Ags.137 An insight 
into this regulation arises from the studies of membrane-bound self-
Ags that induce more potent tolerance in B cells than soluble Ags.79-
81,93 In part, this may be due to more multivalent high avidity mode 
of binding and thus more potent engagement of BCRs and signaling. 
However, B cell tolerance to membrane-bound self-Ags is further 
ensured by specific interactions between type-I transmembrane lec-
tin proteins (Siglecs) and species-specific sialic acid motifs that are 
present on glycans on the surface of most cells (Reviewed in Ref. 
137-140).
Two types of Siglecs lectins, CD22 and Siglec-G, are preferen-
tially expressed on B cells140 and can bind to their ligands both in 
cis (on the surface of the same cell) or in trans (on the neighboring 
cells).141-143 Co-presentation of Ag with Siglecs' sialic acid ligands on 
Ag-presenting cells was shown to promote suppression of BCR sig-
naling and induce an apoptotic signal in cognate B cells ex vivo. This 
result suggested a possible role of Siglec/Siglec ligand interactions 
in the mechanisms of self vs non-self-discrimination.142 The mech-
anism involves phosphorylation of Siglec's cytoplasmic ITIM mo-
tifs through recruitment of phosphotyrosine and phosphoinositide 
phosphatases SHP-1 and SHIP, leading to dephosphorylation of BCR 
signaling machinery and downstream targets.142,144-146 In addition 
to the ex vivo observations, recognition of Ags in conjunction with 
CD22 and Siglec G siglec ligands has been shown to induce B cell tol-
erance in vivo147 and to prevent development of autoAbs.141,148-151
An elegant study illuminated the role of interactions between 
CD22 and Siglec G receptors and sialic acids for induction of toler-
ance in mature B cells.152 The study used an adoptive transfer model 
to address the proliferation and survival of mature HEL-specific Ig-Tg 
B cells upon their in vivo exposure to B cells expressing their cognate 
Ag HEL in membrane-attached form (mHEL). Co-expression of CD22 
and Siglec G on Ig-Tg B cells was required for efficient inhibition of 
their proliferation and rapid death in the presence of mHEL express-
ing B cells. Conversely, deficiency in the preferred ligands of CD22 
(α2-6 linked sialosides) on mHEL-presenting ST6Gal1−/− B cells (that 
lack the enzyme, which catalyzes transfer of sialic acid from CMP-
sialic acid to galactose-containing substrates)153 was sufficient to 
partially restore Ig-Tg B cell proliferation and survival.152 The study 
also demonstrated that CD22 and Siglec-G have distinct partially 
redundant specificities for sialic ligands on the cell surface and can 
be recruited to the immunological synapse with Ag-presenting cells 
independently of each other. It also suggested that B cell deletion 
requires participation of Lyn kinase and pro-apoptotic factor BIM.152
Overall, these and other studies indicate that in the context of 
membrane-bound Ags, CD22 and Siglec G-mediated recognition of 
species-specific natural sialic ligands by B cells (in trans) and their 
recruitment into immunological synapse should potentiate B cell 
tolerance and death in vivo. It is not known if natural sialic ligands 
are expressed by the specialized intact Ag-presenting cells (such as 
SCS macrophages and FDCs) and contribute to defining B cell fate 
to foreign Ags in vivo.
5.3 | Acquisition of Ag in the context of FDCs and B 
cell fate
One of the key questions is whether recognition of Ags by naive B 
cells obeys the rules for the induction of tolerance and AICD in B 
cells when Ag is presented on FDCs. It has been shown that immune 
complexes that are deposited on FDCs and are thus displayed in a 
highly repetitive fashion can trigger T-independent responses and 
even promote formation of GCs in nude mice.154,155 The data sug-
gest that Ags displayed as immune complexes on FDCs can promote 
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Ag-specific B cells to proliferate and initiate early PB and GC re-
sponses even when T cell help is not available,155 possibly due to 
the contribution of co-stimulatory factors (BAFF, IL-6 and C4bBP) 
produced by FDCs.
However, another study suggested that tolerance develops in 
Ig-Tg B cells that encounter self-Ags on FDCs. The study utilized 
CD21cre mDELloxP mice (that express membrane-bound DEL on FDCs 
and B cells) that were irradiated and reconstituted with MD4 BM 
cells to investigate lysozyme-specific Ig-Tg B cell tolerance toward 
self-Ag DEL expressed by FDCs.156 In these mice, transitional and 
follicular Ig-Tg B cells were significantly reduced and B cells escap-
ing negative selection had upregulated BIM and were more prone to 
apoptosis. Interestingly, in contrast to the “classical” anergic B cells, 
BCR signaling in the lysozyme-specific Ig-Tg B cells appeared to be 
intact.
The differences in the results described above could be possibly 
explained by the distinct mouse models that have been utilized, pre-
sentation of immune complexes with foreign Ags vs directly mem-
brane-attached self-Ags on FDCs, or differential effects that Ags 
presented on FDCs exert on the developing vs. mature B cells. It 
remains to be sorted out under which conditions the Ags presented 
on FDCs promote T-independent amplification of B cell responses or 
may lead to induction of B cell tolerance, especially when T cell help 
to B cells is delayed.
6  | REMAINING QUESTIONS AND 
CONCLUDING NOTES
The original “Signal 1 and 2“ model for B cell activation and recruit-
ment into T-dependent response vs development of tolerance has 
been very attractive due to its simplicity and binary predictions. 
However, based on the previous studies and the emerging data, 
significantly more sophisticated scenario of B cell fate decision-
making is likely to take place in vivo. While the timing of T cell help 
availability is one of the major factors that should define B cell fate, 
for a given B cell clone it may also depend on the type of Ag that 
the B cell encounters, where this encounter(s) occurs, for how long 
it proceeds, and which additional signals B cells receive from Ag-
presenting and neighboring cells. Performed herein analysis of di-
verse spatiotemporal scenarios of Ag and T cell help availability for 
B cells in SLO together with the ex vivo/in vivo experimental stud-
ies of B cell activation and tolerance suggest that B cell recruitment 
into T-dependent response in vivo may be influenced by (a) duration 
of B cell exposure to foreign Ag and timing of T cell help, (b) the 
valency of Ag, and (c) the cellular context of Ag acquisition. It also 
reveals outstanding gaps in our understanding of these processes 
that should be further addressed. Below we suggest a few questions 
that emerge from the findings discussed in this review.
Q1: For a given B cell, duration of its exposure to Ag prior to ac-
quisition of T cell help determines the likelihood of its tolerance 
and rapid death. A lot has been learned about the molecular 
mechanisms of B cell activation and anergy.157,158 However, the re-
maining fundamental questions is how BCR signaling is integrated 
over time on the molecular level to determine B cell fate: anergy, 
mitochondrial dysfunction, and ultimately AICD vs. B cell deacti-
vation and return to naive -like state in vivo? Does the “molecular 
integrator” solely depend on the duration of BCR engagement or is 
BCR signaling strength also incorporated into the decision circuit?
Q2: Briefly exposed to Ag B cells undergo rapid apoptosis ex vivo 
but not in vivo, which should be considered in the studies of B 
cell activation, survival, and metabolism. Which factors rescue 
the survival of B cells briefly exposed to Ag in vivo? BAFF (Blys) is 
one of the factors that is likely to contribute to Ag-primed B cell 
survival.159,160 However, whether additional signaling molecules 
and pathways, such as Notch, integrin, or migration-promoting 
chemokine signaling,161 may contribute to the rescue of Ag-
primed B cells from untimely AICD must be further elucidated.
Q3: While our previous evidence suggests no substantial dif-
ference in the responsiveness of naive vs. naive -like (briefly 
exposed to Ag and then inactivated) B cells to protein immuni-
zation, future studies should address whether some transcrip-
tional or metabolic differences persist over time and may affect 
long-term B cell survival in SLO or influence their fate after they 
differentiate into GC, PC, or memory B cells.
Q4: Short-term exposure to Ag is, presumably, not sufficient to 
induce mitochondrial dysfunction in B cells in vivo. However, 
what is the interrelationship between B cell anergy and mito-
chondrial dysfunction? Do all anergic B cells develop mitochon-
drial dysfunction? Are tolerant B cells that develop profound 
mitochondrial dysfunction destined to die? Can mitochondrial 
dysfunction be reversed in anergic B cells after disruption of 
continuous engagement of BCRs?
Q5: Previous studies suggested that there are profound tran-
scriptional differences in the anergic compared to the recently 
activated B cells.100,101 However, it remains to be assessed 
whether these changes are permanent or whether they disap-
pear within some time after B cells exposure to Ags in vivo has 
been discontinued.
Q6: Additional in vivo studies are necessary to test various mod-
els of highly multivalent Ags. We need to better understand how 
the physico-chemical characteristics of Ags (including variable 
Ag concentrations, size, valencies, and epitope densities, to-
gether with other biophysical properties of the Ags) affect the 
activation versus tolerance outcomes for B cells in vivo and their 
recruitment into the PC and GC response.130
Recent studies have opened a new dimension of the pro-sur-
vival or pro-death signals that may be encountered by B cells 
during the process of Ag acquisition in SLO in proximity to 
various distinct Ag-presenting or neighboring cells. At the mo-
ment, this leaves us with multiple opened questions on how 
the local environment of Ag acquisition by naive B cells af-
fects their fate and ability to get recruited into T-dependent 
response vs. undergo rapid death. Among these questions are 
the following:
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Q7: Are sialic acid ligands for CD22 and Siglec-G expressed at 
sufficient levels on Ag-presenting cells, such as macrophages, 
DCs, or FDCs for triggering B cell tolerance?
Q8: Are transient encounters with cells expressing membrane self-
Ags and sialic ligands for CD22/Siglec-G sufficient to trigger B cell's 
AICD in vivo or are prolonged/recurrent encounters required?
Q9: Can sialic ligands contribute to B cell apoptosis when Ags are 
presented as immune complexes rather than transmembrane or 
directly membrane-attached proteins?
Q10: Small soluble Ags that drain into the SLO can be acquired in 
close proximity to other B cells that express sialic ligands of CD22/
Siglec G. Because of this proximity, can sialic ligands/Siglec interac-
tions contribute to the induction of B cell AICD by soluble Ags in vivo?
Q11: Can other signals (eg, BAFF, Notch ligands, integrins, 
chemokines, or other factors) expressed by the Ag-presenting 
cells rescue B cells from apoptosis (or promote it) when T cell 
help is delayed in vivo.
7  | CONCLUDING NOTES
Cumulatively, multiple factors discussed in this review affect the 
diversity of B cell clones recruited into T-dependent responses to 
foreign Ags, as well as the ultimate fate of those cells. It is im-
portant to note that in the case of multicomponent vaccines or 
pathogen infections, B cells reactive with various Ags or antigenic 
fragments are likely to have differential spatiotemporal patterns 
of exposure to those epitopes in vivo and therefore may have dis-
tinct fates.
From the other hand, biophysical properties of self-Ags and 
the duration of their access to SLO may also determine whether 
self-reactive B cells become anergic and are removed from B cell 
repertoire or persist, enabling their potential recruitment into re-
sponses to foreign- or self-Ags. By dissecting the still unresolved 
questions about B cell fate in the context of various scenarios of 
Ag and T cell help acquisition in vivo, we should arrive at a more 
comprehensive “Signal 1, 2 +” model that would enable better 
manipulation of T-dependent B cell responses for vaccination or 
therapeutic purposes.
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